PLEKHH1
gene geneOn this page
Also known as KIAA1200
Summary
PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1, HGNC:17733) is a protein-coding gene on chromosome 14q24.1, encoding Pleckstrin homology domain-containing family H member 1 (Q9ULM0).
Predicted to be located in cytoskeleton.
Source: NCBI Gene 57475 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_020715
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17733 |
| Approved symbol | PLEKHH1 |
| Name | pleckstrin homology, MyTH4 and FERM domain containing H1 |
| Location | 14q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1200 |
| Ensembl gene | ENSG00000054690 |
| Ensembl biotype | protein_coding |
| Entrez | 57475 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 11 retained_intron, 5 protein_coding, 3 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000329153, ENST00000557971, ENST00000558214, ENST00000558296, ENST00000558366, ENST00000558386, ENST00000558981, ENST00000559168, ENST00000559766, ENST00000559832, ENST00000559981, ENST00000560100, ENST00000561057, ENST00000561135, ENST00000561370, ENST00000561456, ENST00000870157, ENST00000870158, ENST00000870159, ENST00000931409
RefSeq mRNA: 1 — MANE Select: NM_020715
NM_020715
CCDS: CCDS45128
Canonical transcript exons
ENST00000329153 — 29 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000807770 | 67533290 | 67533398 |
| ENSE00001632224 | 67569138 | 67569216 |
| ENSE00001668372 | 67555825 | 67555887 |
| ENSE00001710346 | 67559608 | 67559691 |
| ENSE00001715153 | 67562137 | 67562894 |
| ENSE00001765506 | 67557269 | 67557418 |
| ENSE00001767995 | 67561954 | 67562035 |
| ENSE00002218188 | 67541834 | 67541993 |
| ENSE00002561322 | 67587074 | 67589612 |
| ENSE00003463475 | 67573276 | 67573386 |
| ENSE00003505419 | 67574242 | 67574403 |
| ENSE00003509953 | 67579721 | 67579876 |
| ENSE00003542998 | 67585568 | 67585654 |
| ENSE00003560464 | 67580938 | 67581038 |
| ENSE00003573704 | 67583741 | 67583883 |
| ENSE00003576623 | 67578023 | 67578199 |
| ENSE00003607211 | 67577302 | 67577414 |
| ENSE00003610353 | 67582069 | 67582210 |
| ENSE00003612879 | 67583995 | 67584124 |
| ENSE00003635544 | 67575392 | 67575472 |
| ENSE00003636010 | 67572135 | 67572277 |
| ENSE00003636380 | 67579134 | 67579311 |
| ENSE00003639127 | 67585951 | 67586097 |
| ENSE00003641697 | 67578534 | 67578631 |
| ENSE00003651494 | 67569921 | 67570012 |
| ENSE00003679177 | 67575823 | 67576005 |
| ENSE00003684431 | 67573801 | 67573887 |
| ENSE00003690560 | 67576395 | 67576503 |
| ENSE00003690827 | 67571752 | 67571902 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 99.52.
FANTOM5 (CAGE): breadth broad, TPM avg 7.0234 / max 738.3867, expressed in 772 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 140233 | 3.5008 | 352 |
| 140228 | 1.4347 | 546 |
| 140229 | 0.6853 | 301 |
| 140230 | 0.6795 | 184 |
| 140232 | 0.5970 | 94 |
| 140231 | 0.1261 | 62 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of thyroid gland | UBERON:0001119 | 99.52 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 99.48 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 99.40 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 99.31 | gold quality |
| pancreatic ductal cell | CL:0002079 | 99.29 | gold quality |
| thyroid gland | UBERON:0002046 | 99.29 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 99.20 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 99.19 | gold quality |
| spinal cord | UBERON:0002240 | 99.16 | gold quality |
| corpus callosum | UBERON:0002336 | 99.10 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 99.07 | gold quality |
| medulla oblongata | UBERON:0001896 | 98.87 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 98.75 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 98.65 | gold quality |
| ventral tegmental area | UBERON:0002691 | 98.60 | gold quality |
| globus pallidus | UBERON:0001875 | 98.55 | gold quality |
| endothelial cell | CL:0000115 | 98.54 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 98.43 | gold quality |
| medial globus pallidus | UBERON:0002477 | 98.36 | gold quality |
| midbrain | UBERON:0001891 | 98.28 | gold quality |
| substantia nigra | UBERON:0002038 | 98.22 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 98.08 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 98.01 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.81 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.76 | gold quality |
| putamen | UBERON:0001874 | 97.52 | gold quality |
| cerebellum | UBERON:0002037 | 97.45 | gold quality |
| parotid gland | UBERON:0001831 | 97.42 | gold quality |
| Ammon’s horn | UBERON:0001954 | 97.02 | gold quality |
| pons | UBERON:0000988 | 96.92 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-180759 | yes | 1092.60 |
| E-HCAD-35 | yes | 72.65 |
| E-HCAD-25 | yes | 49.93 |
| E-GEOD-84465 | yes | 9.58 |
| E-ANND-3 | yes | 6.99 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
180 targeting PLEKHH1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plekhh1 | ENSDARG00000053835 |
| mus_musculus | Plekhh1 | ENSMUSG00000060716 |
| rattus_norvegicus | Plekhh1 | ENSRNOG00000010650 |
| drosophila_melanogaster | CG43867 | FBGN0264449 |
| caenorhabditis_elegans | WBGENE00003143 |
Paralogs (1): PLEKHH2 (ENSG00000152527)
Protein
Protein identifiers
Pleckstrin homology domain-containing family H member 1 — Q9ULM0 (reviewed: Q9ULM0)
All UniProt accessions (4): Q9ULM0, H0YKY5, H0YLU5, H0YMQ6
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9ULM0-1 | 1 | yes |
| Q9ULM0-2 | 2 |
RefSeq proteins (1): NP_065766* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000299 | FERM_domain | Domain |
| IPR000857 | MyTH4_dom | Domain |
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR014352 | FERM/acyl-CoA-bd_prot_sf | Homologous_superfamily |
| IPR019748 | FERM_central | Domain |
| IPR019749 | Band_41_domain | Domain |
| IPR035963 | FERM_2 | Homologous_superfamily |
| IPR038185 | MyTH4_dom_sf | Homologous_superfamily |
Pfam: PF00169, PF00373, PF00784, PF21989
UniProt features (24 total): sequence variant 6, region of interest 5, domain 4, compositionally biased region 3, splice variant 3, chain 1, coiled-coil region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9ULM0-F1 | 70.81 | 0.33 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 745
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 117 (showing top):
TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, SENESE_HDAC1_AND_HDAC2_TARGETS_DN, GTGCCTT_MIR506, chr14q24, TGCCTTA_MIR124A, HUANG_DASATINIB_RESISTANCE_DN, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ACACTGG_MIR199A_MIR199B, WANG_CISPLATIN_RESPONSE_AND_XPC_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP, DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP, PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN, BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
458 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PLEKHH1 | C7orf57 | Q8NEG2 | 449 |
| PLEKHH1 | SLC16A9 | Q7RTY1 | 434 |
| PLEKHH1 | MYC | P01106 | 416 |
| PLEKHH1 | KIAA0408 | Q6ZU52 | 416 |
| PLEKHH1 | ZFYVE26 | Q68DK2 | 400 |
| PLEKHH1 | RAD51B | O15315 | 389 |
| PLEKHH1 | ABHD18 | Q0P651 | 379 |
| PLEKHH1 | ELOVL2 | Q9NXB9 | 379 |
| PLEKHH1 | RBPMS2 | Q6ZRY4 | 367 |
| PLEKHH1 | TMEM144 | Q7Z5S9 | 345 |
| PLEKHH1 | PRR15 | Q8IV56 | 341 |
| PLEKHH1 | TMEM217B | A0A494BZU4 | 340 |
| PLEKHH1 | TMEM217 | Q8N7C4 | 336 |
| PLEKHH1 | KLHL5 | Q96PQ7 | 335 |
| PLEKHH1 | POLR3GL | Q9BT43 | 333 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BRK1 | HSBP1 | psi-mi:“MI:0914”(association) | 0.740 |
| LPXN | PCNT | psi-mi:“MI:0914”(association) | 0.640 |
| YWHAB | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.480 |
| APBB1IP | ANXA13 | psi-mi:“MI:0914”(association) | 0.350 |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 | |
| FKBP5 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| FKBP8 | GNB5 | psi-mi:“MI:0914”(association) | 0.350 |
| PPP4R1L | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| PTGES3 | SBNO1 | psi-mi:“MI:0914”(association) | 0.350 |
| DKK3 | MYO9A | psi-mi:“MI:0914”(association) | 0.350 |
| BRK1 | KIF5C | psi-mi:“MI:0914”(association) | 0.350 |
| APBB1IP | ACTA2 | psi-mi:“MI:0914”(association) | 0.350 |
| LPXN | MED14 | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA10 | KANSL1L | psi-mi:“MI:0914”(association) | 0.350 |
| ARGLU1 | PIAS2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PLEKHH1 | psi-mi:“MI:0915”(physical association) | 0.000 | |
| CHAF1B | PLEKHH1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-RNA), PLEKHH1 (Proximity Label-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS), PLEKHH1 (Affinity Capture-MS)
ESM2 similar proteins: A0A8I3NFE2, A0FI79, B1AVH7, B5DFA1, D2H0G5, D7PF45, O00750, O15357, O70143, P29353, P97573, P98083, Q00IB7, Q0IIE2, Q15678, Q16825, Q17R13, Q2I6J0, Q2I6J1, Q2V2M9, Q5JV73, Q5M824, Q5R7W7, Q5U2X5, Q61120, Q62130, Q62136, Q62728, Q62925, Q69Z98, Q6P4S2, Q6P549, Q80TI1, Q8AY68, Q8BMC3, Q8BYW1, Q8IWQ3, Q8K245, Q92529, Q92835
Diamond homologs: A1CFB3, A1CYS1, A2QNQ5, A7A179, A7ERM5, A7KAK6, A7KAN4, A7TF84, C4B4E5, I1S8Q3, P0CN90, P0CN91, Q00IB7, Q06321, Q08001, Q0CKU4, Q0UY53, Q2U0C3, Q4WID6, Q54IL5, Q5A950, Q5B4C9, Q6BN88, Q6C8M8, Q6CUV2, Q751Z4, Q7S1I0, Q80TI1, Q8C115, Q8CI52, Q8IVE3, Q8N4B1, Q8NJS1, Q9F2F9, Q9M8Z7, Q9ULM0, Q9XIG1, Q9Y751, Q3KR37, Q3KR56
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4971 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:67541817:T:TA | acceptor_gain | 1.0000 |
| 14:67541820:A:AG | acceptor_gain | 1.0000 |
| 14:67541820:AT:A | acceptor_gain | 1.0000 |
| 14:67541820:ATGCT:A | acceptor_gain | 1.0000 |
| 14:67541821:T:G | acceptor_gain | 1.0000 |
| 14:67541821:T:TA | acceptor_gain | 1.0000 |
| 14:67541824:T:A | acceptor_gain | 1.0000 |
| 14:67541832:A:AG | acceptor_gain | 1.0000 |
| 14:67541832:A:C | acceptor_loss | 1.0000 |
| 14:67541832:AG:A | acceptor_gain | 1.0000 |
| 14:67541832:AGG:A | acceptor_gain | 1.0000 |
| 14:67541833:G:GA | acceptor_gain | 1.0000 |
| 14:67541833:GG:G | acceptor_gain | 1.0000 |
| 14:67541833:GGG:G | acceptor_gain | 1.0000 |
| 14:67541833:GGGC:G | acceptor_gain | 1.0000 |
| 14:67541992:AGG:A | donor_loss | 1.0000 |
| 14:67541994:G:GG | donor_gain | 1.0000 |
| 14:67541994:GT:G | donor_loss | 1.0000 |
| 14:67555814:T:TA | acceptor_gain | 1.0000 |
| 14:67557265:TCAG:T | acceptor_loss | 1.0000 |
| 14:67557266:CAGG:C | acceptor_loss | 1.0000 |
| 14:67557267:A:AT | acceptor_loss | 1.0000 |
| 14:67557267:AGGT:A | acceptor_gain | 1.0000 |
| 14:67557267:AGGTG:A | acceptor_gain | 1.0000 |
| 14:67557268:G:A | acceptor_loss | 1.0000 |
| 14:67557268:GGT:G | acceptor_gain | 1.0000 |
| 14:67557268:GGTG:G | acceptor_gain | 1.0000 |
| 14:67557268:GGTGG:G | acceptor_gain | 1.0000 |
| 14:67557415:GCAG:G | donor_gain | 1.0000 |
| 14:67557416:CAGG:C | donor_loss | 1.0000 |
AlphaMissense
8869 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:67574302:T:A | W663R | 0.998 |
| 14:67574302:T:C | W663R | 0.998 |
| 14:67576401:T:A | W787R | 0.997 |
| 14:67576401:T:C | W787R | 0.997 |
| 14:67577407:T:C | L856P | 0.997 |
| 14:67578033:T:C | L862P | 0.997 |
| 14:67578084:T:C | L879P | 0.997 |
| 14:67578087:C:A | A880D | 0.997 |
| 14:67578126:T:C | L893P | 0.996 |
| 14:67578544:T:C | L921P | 0.996 |
| 14:67573301:T:C | L585P | 0.995 |
| 14:67573342:T:A | W599R | 0.995 |
| 14:67573342:T:C | W599R | 0.995 |
| 14:67577397:G:C | A853P | 0.995 |
| 14:67578036:T:C | F863S | 0.995 |
| 14:67578150:T:C | L901P | 0.995 |
| 14:67579286:T:A | V1001E | 0.995 |
| 14:67573345:T:C | F600L | 0.994 |
| 14:67573347:T:A | F600L | 0.994 |
| 14:67573347:T:G | F600L | 0.994 |
| 14:67574304:G:C | W663C | 0.994 |
| 14:67574304:G:T | W663C | 0.994 |
| 14:67576414:T:C | L791P | 0.994 |
| 14:67578099:T:C | L884P | 0.994 |
| 14:67579225:G:A | E981K | 0.994 |
| 14:67579241:T:C | L986P | 0.994 |
| 14:67580959:T:A | W1069R | 0.994 |
| 14:67580959:T:C | W1069R | 0.994 |
| 14:67555855:G:C | A53P | 0.993 |
| 14:67575980:T:C | L776P | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000053876 (14:67534513 ATTG>A), RS1000063970 (14:67546962 G>T), RS1000074186 (14:67536492 A>G), RS1000090398 (14:67540224 G>A), RS1000099512 (14:67570108 T>C), RS1000130537 (14:67548497 A>T), RS1000283168 (14:67572687 G>A), RS1000333285 (14:67542862 G>A), RS1000345995 (14:67559417 G>C), RS1000390503 (14:67567244 G>A,T), RS1000526191 (14:67551761 C>T), RS1000528578 (14:67531350 A>T), RS1000622179 (14:67574001 A>T), RS1000708220 (14:67546688 G>A), RS1000777556 (14:67559215 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001414_23 | Phospholipid levels (plasma) | 9.000000e-18 |
| GCST005342_7 | Plasma kynurenine levels in major depressive disorder | 5.000000e-06 |
| GCST006627_59 | Diastolic blood pressure | 8.000000e-10 |
| GCST008928_10 | Phosphatidylcholine-ether levels | 9.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008529 | kynurenine measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0010227 | phosphatidylcholine ether measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation, decreases expression, affects cotreatment | 2 |
| Acetaminophen | increases expression | 2 |
| Nickel | decreases expression | 2 |
| Tretinoin | decreases expression, increases expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| titanium dioxide | increases expression | 1 |
| sodium arsenite | decreases expression, increases abundance, affects cotreatment | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Estradiol | increases expression | 1 |
| Manganese | increases abundance, affects cotreatment, decreases expression | 1 |
| Quercetin | increases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D8TC | Ubigene HCT 116 PLEKHH1 KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.